Background and Objectives: Multidrug-resistant (MDR) Mycobacterium tuberculosis strains are serious threats to the control of tuberculosis and comprise an increasing public health problem. Rapid detection of such strains is quite critical in timely management of such issues. The study was performed with an objective to compare Genotype MTBDRplus reverse hybridization probe assay (Hain Lifescince, GmBH, Nehern, Germany) with culture based proportion method for rapidly identifying MDR-TB strains from suspected multi drug resistant cases, referred to GENETUP Kathmandu, Nepal.
INTRODUCTION
Tuberculosis presents a significant health threat to the world's population, with 8 million new cases of disease and 2 million deaths per year [1] . Drug-resistant TB is increasing in many parts of the world, and high rates of multidrugresistant TB-causing (MDR-TB) isolate, resistant to at least isoniazid [INH] and rifampin [RMP] , have been reported in several countries [2] . 450,000 new MDR-TB cases are estimated to occur every year [1] . One of the most alarming trends concerning tuberculosis is the emergence of drug-resistant Mycobacterium tuberculosis strains, which has become a global public health problem [3] .
In Nepal latest survey conducted in 2001/2002 showed MDR-TB constitutes of 1.3% of initial TB cases, 20.4% in acquired cases and 2.4% of TB patients were co-infected with HIV [4] . The worldwide increase in the rates of multidrugresistant (MDR) tuberculosis has made the timely identification of resistant Mycobacterium tuberculosis strains extremely important to achieve effective diseases management to prevent their spread. INH and RMP are the most important first-line antituberculosis drugs and resistance to these drugs often results in treatment failures and fatal clinical outcomes [5] .
MDR strains are serious threats to the control of tuberculosis and comprise an increasing public health problem. Patients infected with MDR strains, are difficult to cure and more likely to remain sources of infection for a longer period of time than are patients with drug-susceptible strains [6] . Treatment for MDR TB patients required use of second -line drugs for more than 24 months. These drugs are more costly, toxic, and less effective than first-line drug used for routine treatment of TB [7] .
In a research performed by Ghimire et al., high rates of MDR-TB isolates were obtained in Nepal. Among the total studied cases, 12.9% isolates were resistant to one or more antituberculosis drug (Rifampicin, Ethambutol, and Isoniazid & Streptomycin) with initial and acquired MDR 4.6% and 5% of the isolated respectively [8] . This indicated the utmost requirement of a tool for rapid detection of such MDR strains for timely management of such issues. The present study aimed to determine the sensitivity and specificity of MTBDRplus assay for the rapid detection of INH and RMP resistance-associated mutations in rpoB, katG and inhA genes from culture specimens in comparison with conventional drug susceptibility testing as a Gold standard.
MATERIALS AND METHODS
A total of 77 sputum specimens collected from suspected and confirmed MDR-TB patients, resistant to at least isoniazid and rifampicin, visiting different DOTS plus centers of Nepal and referred to German Nepal Tuberculosis Project (GENETUP) Hospital, National Reference Laboratory, Kathmandu.
Sample Collection and processing
The sputum specimens of MDR-TB suspected patients were sent from different DOTS plus centers in five development regions of Nepal in leak proof, wide mouth, transparent, sterile and stoppered plastic containers were obtained. All collected sputum specimens were processed for Fluorescence microscopy, culture on Lowenstein-Jensen medium by proportion method which were then analyzed by Genotype MTBDRplus assay.
Conventional Drug Susceptibility Test
Several 100-fold serial bacilli dilutions were inoculated into drug-containing and drug-free (control) media. The number of colonies obtained in the drug-containing and control media were enumerated. If the proportion of resistant bacteria was higher than 1% for isoniazid, rifampicin and para-aminosalycilic acid, or 10% for the other drugs, the strain was considered resistant and the results were taken otherwise, the test was read again at 42 days of incubation to assess if the strain was susceptible to a certain drug [9] .
Genotype MTBDRplus assay
This assay was performed as per standard protocol provided by the manufacturer (Hain Lifescience GmbH, Nehren, Germany). Briefly it was performed in three steps.
DNA extraction:
A few colonies of pure culture were suspended in 300µl of DNA free water in an extraction tube. The suspension was heated at 95°C for 20 minutes and then incubated for 15 minutes in an ultrasonic bath. The content was centrifuged at 13,000Xg for 8 minutes. A clear supernatant containing DNA genome was transfer to new tube and used for PCR.
Amplification process in multiplex PCR:
For amplification, the mixture contained 35µl of the primer nucleotide mix, 5µl of 10X polymerase incubation buffer, 2µl of 25 mM MgCl2, 0.2 µl of AmpliTaq Gold polymerase (5U/I; Applied Biosystems),3µl of DNA free water and 5µl of the supernatant of the cell lysate, for a final volume of 50µl was prepared. The amplification protocol consisted of 5 minutes of denaturation at 95°C and 2 minutes at 58°C, an additional 20 cycles comprising 25seconds at 95°C, 40 seconds at 53°C and 40 seconds at 70°C and then a final extension at 70°C for 8 minutes.
Hybridization (performed as per the protocol by Hain Lifescience GmbH, Nehren, Germany)
Briefly, 20 µl of denaturation solution (DEN, blue) was dispensed in a corner of each of the wells used. Amplified solution of 20µl was added and pipetted up and down to mix well then incubated at room temperature for 5 minutes.1 ml of prewarmed hybridization buffer (HYB, green) was carefully added, then gently shaked the tray until the solution had a homogenous colour. DNA strip was placed in each well. The tray was placed in shaking water bath/Twincubator and incubated for 30 minutes at 45°C. Hybridization buffer was completely aspirated out. 1 ml of stringent wash solution (STR, red) was added to each strip and incubated for 15 minutes at 45°C in shaking water bath/twincubator. The following steps were performed at room temperature. Stringent wash solution was completely removed. Each strip was washed once with 1 ml of rinse solution (RIN) for 1 minute on shaking platform/twincubator and RIN was poured out after incubation. 1 ml of diluted conjugate was added to each strips and incubated for 30 minutes on twincubator. The solution was removed and washed each strip for 1 minute with 1 ml of Rinse solution and once for 1 minute with 1 ml distilled water and poured out solution each time. 1 ml of diluted substrate (1:100) dimethyl sulfoxide was added to each strip and incubated protected from light without shaking for approximately 10 minutes. Reaction was stopped by briefly rinsing twice with distilled water.
Strips were removed by using tweezers from tray and dried them between two layers of absorbent paper.
RESULTS

Total MDR cases:
Out of total 77 sputum specimens, 70 samples were detected as MDR cases by conventional drug susceptibility testing by proportion method, remaining 7 samples were detected as Atypical mycobacterium. 
DISCUSSION
Drug resistance in Mycobacterium tuberculosis
isolates is the result of random genetic mutations in particular genes conferring resistance. Drug resistance in those clinical isolates can be assessed rapidly within one working day by molecular assay. The Genotype MTBDRplus assay allows rapid and specific detection of the most-frequent mutations leading to INH and RMP resistance [10] .
A useful strategy for diagnosis of drug resistance to RMP in Mycobacterium tuberculosis is the detection of mutations in rpoB gene because mutations in the 81bp hot spot region of rpoB are predominant (average, 95%) [11] . Additional analysis of codon 315 of katG facilitates the detection of the most-frequent mutations associated with INH resistance [12] . The test has an advantage of multiplex PCR in combination with reverse hybridization followed by biotin-streptavidin-mediated detection of hybridized PCR fragments on membrane strips coated with target-specific oligonucleotides. The presence of wild-type or mutated DNA sequences in the 81-bp hot spot region of rpoB ,codon 315 of katG and regulatory region of inhA gene is then shown by clear-cut hybridization signals on the membrane strips and the results are easy to interpret without the extensive expert knowledge. The new MTBDRplus assay can even be applied directly to smear-positive specimens, with a turnaround time of approximately 6 hr., and save several weeks of time required for conventional DST. The Genotype MTBDRplus assay suffers from few limitations for the detection of antibiotic resistance. The genetic basis of resistance is not fully understood for all Mycobacterium tuberculosis isolates. This means that detection of mutation associated with resistant is clinically relevant, but a lack of mutation in the target gene does not necessarily mean that the organism is susceptible to the drug. A variable proportion of resistant isolates were detected as susceptible by MTBDRplus assay. More importantly, little information is available regarding genomic mutation pattern of Mycobacterium tuberculosis associated with RMP and INH resistance in Nepal. However, running a confirmatory conventional DST, when needed, will eliminate such issues.
CONCLUSION
The Genotype MTBDRplus assay is valuable as a primary screening tool for MDR Mycobacterium tuberculosis isolates/suspects due to its high sensitivity, short working time and easy to include in routine workflow. The assay can even be performed directly from sputum samples of suspected patients. It can be incorporated as a part of procedure in short term treatment course therapy for newly suspected resistant cases. With this rapid and reliable tool, the therapeutic management of patients can be optimized. The containment of MDR-TB strains is a big challenge for present and future Nepal. A rapid diagnosis technique like Genotype MTBDRplus assay is essential to counteract such challenges.
